Efficacy and Safety of Chidamide in CBF Leukemia

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2017
In this open-label, randomized, prospective clinical trial, CBF acute myeloid leukemia (AML) patients who have reached CR are randomised into two groups and receive high-dose cytarabine (HDAC) or high-dose cytarabine plus chidamide.The safety and efficacy of chidamide is evaluated.
Epistemonikos ID: 932df03257db23ea261bb4026c6adb68976e729b
First added on: Jan 21, 2022